Cover Image
QR Code

Precautionary harm disclosure in clinical trials.

Published in:American Journal of Bioethics Vol. 9; no. 8; pp. 43 - 46
Main Author: Wu KC
Format: commentary Journal Article
Published: Taylor & Francis Ltd Aug2009
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105383504&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105383504
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15265161
        FKZ
      jtl: American Journal of Bioethics
      issn: 15265161
      maglogo: N
    pubinfo:
      dt: Aug2009
      vid: 9
      iid: 8
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        105383504
        2010344443
        10.1080/15265160902948348
        NLM19998161
        105383504
      ppf: 43
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Precautionary harm disclosure in clinical trials.
      aug:
        au: Wu KC
        affil: National Taiwan University College of Medicine,
      sug:
        subj:
          Adverse Health Care Event Ethical Issues
          Clinical Trials Adverse Effects
          Clinical Trials Ethical Issues
          Clinical Trials Legislation and Jurisprudence
          Consent (Research)
          Research Subjects
          Truth Disclosure Ethical Issues
          Autonomy
          Government Regulations
          Pharmaceutical Companies
          Serotonin Uptake Inhibitors Adverse Effects
          Suicide Chemically Induced
          United States
          United States Food and Drug Administration
      pubtype: Academic Journal
      doctype:
        commentary
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N